Get documents about "GUIDE Pulmonary embolism
Document Sample
April 2007
To: Meeting Organizers and Pharmacy Continuing Education Planners
CC: UW Office of Conferences and Institutes
Members of the Tripartite Committee on Continuing Education for Pharmacists in
Wyoming (“TPC”)
From: Joan M Anderson, Coordinator for Continuing Education
UW School of Pharmacy/ Tripartite Committee
Re: Planning your next Pharmacy Continuing Education Event
Representing the “TPC”, an ACPE-accredited continuing education provider, it is my
responsibility to assure and maintain documentation showing that all programs advertised and
offered for ACPE credit from the “TPC” consistently meet ACPE criteria.
Your efforts to provide sound, interesting, and effective ACPE-accredited continuing education
programs to Wyoming pharmacists and technicians must be based on the criteria included in the
attached „Guide‟.
ACPE Criteria now include 26 categories, described and interpreted in 69 pages, and the
essentials which apply to your planning process are summarized in the attached „Guide‟. In
October 2006, a revised Definition of Continuing Education for the Profession of Pharmacy was
approved by the ACPE Board of Directors, for implementation August 1, 2007. Also, an
expanded Standard for non-commercialism (Criterion 17) was established, and the
implementation transition period runs through December 31, 2007.
Questions about implementing these standards for your Pharmacy Continuing Education
program should be directed to me as your liaison with ACPE. The application for the ACPE
Universal Program Number (UPN) for each presentation in your event is based on the
information you provide to me on the attached “checklist” and that should be submitted to me 6
weeks prior to the event.
If your program planning and delivery is managed entirely by an association member or staff,
that person must submit a copy of your program announcements, budget, participant handouts,
presenter evaluations, to Tia Farmer at the School of Pharmacy when the program is complete.
Note: no participant will receive a statement of credit until Tia has received his/her evaluation
for each presentation.
If you are working with the University‟s Office of Conferences and Institutes, they will forward
these materials to Tia Farmer when the program is complete.
Before you send advance program information to the potential participants, please check the
requirements associated with Criterion # 5(pages 2 & 3 in the „Guide‟) regarding use of the
ACPE logo and the Tripartite Committee name.
GUIDE
For
Planning ACPE Accredited Pharmacy Continuing Education Programs
Prepared by the:
Tripartite Committee on Continuing Education for Pharmacists in
Wyoming
April 2007
Joan Anderson
Tia Farmer
Table of Contents
Table of Contents ......................................................................................................................................................2
CRITERION 5 Program announcement literature ..........................................................................................3
Guideline 5.1 ........................................................................................................................................................3
Guideline 5.2 ........................................................................................................................................................4
Guideline 5.3 ........................................................................................................................................................4
Guideline 5.4 ........................................................................................................................................................4
Guideline 5.5 ........................................................................................................................................................4
ACPE Continuing Education Program Planning Checklist......................................................................................5
CRITERION 18 Educational objectives.............................................................................................................6
Guideline 18.1 ......................................................................................................................................................6
Guideline 18.2 ......................................................................................................................................................6
Guideline 18.3 ......................................................................................................................................................6
Developing Learning Objectives ..........................................................................................................................6
Topics ....................................................................................................................................................................7
Drugs/Devices ........................................................................................................................................................8
ACPE Statement on Non-Commercialism of Pharmacy Continuing Education .......................................................9
FACULTY AND STAFF .......................................................................................................................................... 10
CRITERION 12 Faculty: qualitative considerations ....................................................................................... 10
CRITERION 13 Faculty: quantitative considerations ..................................................................................... 10
EDUCATIONAL PROGRAM DEVELOPMENT .................................................................................................... 10
CRITERION 15 Appropriate subject matter .................................................................................................... 10
CRITERION 16 Educational needs assessment ............................................................................................... 10
CRITERION 17 Non-commercialism ............................................................................................................... 10
CRITERION 18 Educational objectives........................................................................................................... 11
CRITERION 19 Topic development ................................................................................................................. 11
CRITERION 20 Instructional materials .......................................................................................................... 11
METHODS OF DELIVERY .................................................................................................................................... 11
CRITERION 21 Instructional delivery methods .............................................................................................. 11
CRITERION 22 Participant involvement in learning ...................................................................................... 11
Updated 4/07
Page 2
CRITERION 5 Program announcement literature
The promotion and advertising of each continuing education activity shall be conducted
in a responsible fashion.
Guideline 5.1
Adequate advance information should be provided to prospective participants in order to
enable them to be well-informed consumers of continuing education programs.
Promotional materials (e.g., brochures, advertisements, memoranda, letters of
invitation,
or other announcements) should clearly and explicitly include at least the following key
informational items:
(A) The educational goals and specific learning objectives of the particular program;
(B) The nature of the target audience(s) that may best benefit from participation in
the program;
(C) The faculty members and their credentials;
(D) The fees for the program and a clear statement of the items that are and are not
covered by those fees, as well as any applicable deadlines for pre-program
cancellations and fee refunds;
(E) The schedule of the educational activities;
(F) The amount of continuing education credit, specified in contact hours or CEUs,
that can be earned through participation in and successful completion of the
program;
(G) The official ACPE logo, used in conjunction with a statement identifying the
accredited Provider(s) sponsoring or cosponsoring the program, according to the
exact language of the prescribed statement: "The [Tripartite Committee on
Continuing Education for Pharmacists in Wyoming] is/are accredited by the
Accreditation Council for Pharmacy Education as a Provider of continuing
pharmacy education."
Note: This statement should be used only in close conjunction with the ACPE logo.
(H) The ACPE Universal Program Number assigned to the program by the
accredited Provider;
Note: For a full description of the procedures for developing the Universal Program
Number for each program, see the glossary.
(I) A full description of all requirements established by the Provider for successful
completion of the continuing education program and subsequent awarding of
credit (e.g., passing a post-test at a prespecified proficiency level, completing a
Updated 4/07
Page 3
program evaluation form, participating in all sessions or certain combinations of
sessions which have been designed as a program package, etc.).
(J) Acknowledgment of outside organization(s), if any, providing financial support for
any component of the educational activity,
(K) In the case of ongoing programs (mediated and live), the initial release date.
Guideline 5.2
In programs where both educational and non-educational sessions are planned, the
sessions being offered as continuing pharmacy education sessions for credit should be
clearly identified.
Guideline 5.3
In the case of home study and other forms of mediated instruction (e.g., journal articles,
monographs, audio and video cassette guided study programs, teleconference and
satellite broadcasts, computer assisted instruction, etc.), all of the informational items
noted in Guideline 5.1 above should be incorporated directly into the printed, recorded
and/or otherwise transmitted educational activities and materials.
Guideline 5.4
In all live programs where statements of credit are not awarded immediately upon
completion of the program, and in all other programs where statements of credit are not
immediately issued, a notice should be incorporated into the promotional materials
indicating when and how a participant may expect to receive a statement of credit.
Guideline 5.5
Promotional materials should represent the educational program being offered in a fair
and responsible manner.
Updated 4/07
Page 4
ACPE Continuing Education Program Planning Checklist
Tripartite Committee on Continuing Education for Pharmacists in Wyoming
1. Submit one of these checklists for each presentation. DUE 6 weeks before event.
Program name/organization____________________________________________
Date ________________ Location _________________ Planner _______________
Format ______________ Contact Hours ____________ (do not include meals)
Presenter __________________________________________________________
Presentation Title ____________________________________________________
Learning Objectives (see “Educational Objectives”/Criterion 18 for suggestions): Upon completion of
this program, the participant will be able to:
1. ____________________________________________________________
2. ____________________________________________________________
3. ____________________________________________________________
4. ____________________________________________________________
Categories:
___Disease State Management/DrugTherapy; ___AIDS Therapy; ___Law (related to Pharmacy
Practice); ___General Pharmacy; ___Patient Safety
Topics (see topic/drug/devices list):
Presenter contact information: Email _____________________________________
Mailing address _____________________________________
_________________________________________________
Phone(s)/FAX __________________ __________________
2. In “Ready-to-Copy” form: Due 2 (or more*) weeks before event
___Presenter’s “commercialism” statement ___Presenter’s brief CV or resume
ALSO, send the items below to the person/agency preparing handout materials in time *to meet
production deadlines for participant handout materials.
___Participant evaluation/exam ___Presentation materials ___Presentation handout
Submit to: Joan Anderson, 2826 West B Street, Torrington, WY 82240
(H) 307-532-2840 (C) 307-575-9691 janderson@netcommander.com
Updated 4/07
Page 5
CRITERION 18 Educational objectives
Continuing education programs shall involve planning which includes written educational goals
and specific learning objectives that are measurable and which may serve as a basis for
evaluating the program's effectiveness.
Guideline 18.1
Educational goals and specific learning objectives should reflect the relationship of the
program topic(s) or content to contemporary pharmacy practice.
Guideline 18.2
Educational goals should be developed early in the program planning process so as to
enable them to provide guidance and direction for all subsequent program development
including content, supplemental instructional materials, learning assessment activities,
and program evaluation.
Guideline 18.3
Goals and objectives should be appropriate for the amount of time allocated to the
program.
Developing Learning Objectives
By
Caffarella RS. Planning Program for Adult Learners, San Francisco, Jossey Bass, 1994
Acquisition of Enhancement of Development of Changes in Attitudes,
Knowledge Thinking Skills Psychomotor Skills Values and/or
Feelings
To identify To reflect To demonstrate To challenge
To list To compare To produce To defend
To define To contrast To assemble To judge
To describe To catalogue To adjust To question
To state To classify To install To accept
To prepare To evaluate To operate To adopt
To recall To forecast To detect To advocate
To express To formulate To locate To bargain
To categorize To investigate To isolate To cooperate
To chart To modify To arrange To endorse
To rank To organize To build To justify
To distinguish To plan To conduct To persuade
To explain To research To check To resolve
To outline To study To manipulate To select
To inform To translate To fix To dispute
To label To differentiate To lay out To approve
To specify To analyze To perform To choose
To tell To compute To sort To feel
To devise To construct To care
To review To draw To express
Updated 4/07
Page 6
Topics
Acne Fever Pain
Addiction Gastroenterology Pain Management
Administration Gastroesophageal Reflux Disorder Parkinson’s Disease
Adverse Drug Reactions (GERD) Pediatrics
AIDS Geriatrics Pelvic Inflammatory Disease (PID)
Alcoholism Glaucoma Peripheral Artery Disease (PAD)
Allergies Gynecology Pharmaceutical Care
Alzheimer’s disease Headache Pharmacoeconomics
Anemia Heartburn Pharmacogenomics
Angina Hemorrhoids Pharmacokinetics
Arrhythmias Hepatitis Platelet Disorders
Arthritis Herbal Medicine Pneumonia
Asthma Herpes Precepting
Atherosclerosis HIPAA Pregnancy
Atrial Fibrillation Human Immunodeficiency Virus (HIV) Premenstrual Syndrome (PMS)
Atrial Flutter Hypercholesterolemia Preventative Medicine
Attention Deficit Hyperactivity Disorder Hyperglycemia Psoriasis
(ADHD) Hyperlipidemia Psychiatry
Benign Prostatic Hypertrophy (BPH) Hypertension Psychology
Billing Immunizations Psychotherapy
Biotechnology Importation Pulmonary Embolism
Burns and Scalds Infectious Disease Pulmonary Hypertension
Cancer Infertility Reimbursement
Cardiology Inflammatory Bowel Disease Renal Disease
Cardiovascular Disease Influenza Rheumatoid Arthritis
Cerebrovascular Disease Insomnia Rhinitis
Clinical Trials Irritable Bowel Syndrome Schizophrenia
Common Cold JCAHO Seizure
Communication Laboratory Sexual Dysfunction
Community-Acquired Pneumonia (CAP) Law Sexually Transmitted Diseases
Compounding Long-Term Care Sickle Cell Disease
Congestive Heart Failure (CHF) Managed Care Sinusitis
Constipation Management Sleep Apnea
Coronary Artery Disease (CAD) Marketing Smallpox
Coronary Heart Disease (CHD) Medicaid Smoking Cessation
Cough Medical Errors Sports Medicine
Counseling Medicare Stevens - Johnson syndrome
Deep Vein Thrombosis (DVT) Medication Errors Stroke
Dementia Meningitis Substance Abuse
Depression Menopause Sunburn
Dermatitis Men’s Health Systemic Lupus Erythematosus (SLE)
Dermatology Mental Health Teaching
Diabetes (DM) Migraine Terrorism
Dialysis Multiple Sclerosis Thrombosis
Diarrhea Myocardial Infarction Thyroid Disease
Drug Information Nausea Toxicology
Drug Interactions Nephrology Transient Ischemic Attack (TIA)
Drug Manufacturing Neurology Transplantation
Drug Overdose New Drugs Ulcers
Drug Use Evaluation (DUE) Nuclear Urinary Incontinence
Dyslipidemia Nutrition Urology
Eczema Obesity Varicella Zoster Virus
Embolism Obstetrics Veterinary Medicine
Emergency Medicine Oncology Viral Infections
Endocrinology Ophthalmology Weight Management
Epilepsy Osteoarthritis Withdrawal
Erectile Dysfunction Osteoporosis Women’s Health
Ethics Ostomy Wound Healing
Updated 4/07
Page 7
Drugs/Devices Beta-Adrenergic Blocking Agents Investigational Agents
Abortifacients Beta-Blockers Laxatives
Acne Products Beta-Lactamase Inhibitors Leukotriene Receptor Antagonists
Aldosterone Receptor Bisphosphonates Low Molecular Weight Heparins (LMWH)
Alpha Adrenergic Agonists Glucose Monitoring Devices Macrolides
Alpha/Beta-Adrenergic Blocking Agents Bronchodilators MAO Inhibitors
Alpha-1 Receptor Agonist Calcium channel Blocking Agents Monoclonal Antibody
Alpha-Glucosidase Inhibitors Carbapenems Narcotics
Aminoglycosides Cephalosporins and Related Products Nasal Decongestants
Amphetamines Chemotherapy Nicotine Replacement
Analgesics Cholesterol Lowering Agents Nitroglycerin
Androgens Cholinergic Agents Nonsteroidal Anti-Inflammatory Drugs
Anesthetic Agents Cholinesterase Inhibitors (NSAIDS)
Angiotensin Converting Enzyme (ACE) Clotting Factors Noradrenergic Agents
Inhibitor Clycoprotein IIb/IIIa Blockers Opiates
Anorexiants Contraception Opioids
Antacids Controlled substances Opthamalics
Antiarrhythmic Agents Corticosteroids Oral Contraceptives
Antiarthritic Agents COX-2 Inhibitors Over-the-Counter Treatment
Antiasthmatic Agents Cytokines Penicillins
Antibacterial Agents Decongestants Phosphodiesterase Inhibitor
Anticholinergic Agents Delivery Systems & Devices Progestins
Anticoagulant Agents Diagnostics Protease Inhibitors
Anticonvulsant Agents Disease Modifying Antirheumatic Drugs Proton Pump Inhibitor
Antidepressant Agents (DMARDs) Quinolones
Antidiabetic Agents Diuretics Salicylates
Antidiarrheal Agents Dopamine Agonists Sedatives and Hypnotics
Antiemetic Agents Estrogen Receptor Antagonists Selective Serotonin Reuptake Inhibitors
Antiepileptic Drugs (AEDS) Estrogens (SSRI)
Antifungal Agents Fibrinolytics Self-Monitoring Devices
Antihistamines Fluoroquinolones Skeletal Muscle Relaxants
Antihyperlipidemic Agents Gonadotropin-Releasing Hormone Agents Statins (HMG_COA) Reductase Inhibitors
Antihypertensive Agents Growth Hormone Receptor Antagonists Stimulants
Antimalarial Agents H2-Receptor Antagonists Stool softeners
Antimicrobial Agents Herbal Medications Sulfonamides
Antineoplastic Agents Herbal Supplements Testosterone
Antiobesity Agents Histamine Antagonists Tetracyclines
Antiparasitic Agents Hormones Thrombolytic agents
Antiplatelet Agents Immune Globulin Tissue Plasminogen Activator (tPA)
Antipsychotic Agents Immunomodulators Topical Agents
Antipyretic Agents Immunosuppressive Agents Unfractionated Heparins
Antiretroviral Agents Immunotherapy Uricolytic agents
Antispasmodic Agents Impotence Agents Vaccines
Antithrombotic Therapy Inhalants Vasodilators
Antiviral Agents Insulin Vitamins
Appetite Suppressants Insulin Delivery Systems
Beta-2-Agonists Interferons
Updated 4/07
Page 8
ACPE Statement on Non-Commercialism of Pharmacy Continuing
Education
Tripartite Committee on Continuing Education for Pharmacists in Wyoming
“All continuing pharmacy education (CPE) programs should provide for an in-depth
presentation with fair and full disclosure and equitable balance. Appropriate topics and
learning activities shall be distinguished from topics and learning activities which are
promotional or appear to be intended for the purpose of endorsing either a specific
commercial drug or other commercial product (as contrasted with the generic
product/drug entity and its contents or the general therapeutic area it addresses), or a
specific commercial service (as contrasted with the general service area and/or the
aspects or problems of professional practice it addresses).”
ACPE Criterion 17—Non-commercialism. Oct 2006.
Presenters in any ACPE-accredited continuing education offering will acknowledge and
disclose any commercial affiliation and such information will be made available to the
audience. The disclosure forms for all presenters will be kept on file; in the event of
future presentation(s), the presenter will be asked to review and update the disclosure
statement.
Programming offered by the Tripartite Committee for ACPE accreditation shall exhibit
fair content balance, providing the audience with information of different perspectives
from which to develop an informed professional opinion.
Disclosure Declaration
____ I have no actual or potential conflict of interest in relation to this program
____ I have a financial interest/arrangement or affiliation with one or more
organizations that could be perceived as a real or apparent conflict of interest in the
context of the subject of this presentation.
Financial Interest Name of Organization
Receive grant/research support _______________________________
Consultant _________________________________
Clinical Investigator _________________________________
Speaker’s Bureau _________________________________
Major Stock Holder _________________________________
Other Financial/Material Support _________________________________
Signature _______________________________ Date ______________
Print name ________________________________
Updated 4/07
Page 9
Additional ACPE Criteria to be considered by program planners include those summarized
below. The complet guidelines for each statement of criteria are available at the ACPE
website, www.acpe-accredit.org, at the “CE provides” section, or contact Tia Farmer if you
would like to have a hard copy.
FACULTY AND STAFF
The quality of continuing pharmacy education programs and their value to participating
pharmacists depends heavily on the ability and expertise of the faculty and support staff.
CRITERION 12 Faculty: qualitative considerations
The faculty for each particular continuing pharmacy education program shall be competent
in the subject matter and qualified by experience, training, and/or preparation to the tasks
and methods of delivery.
CRITERION 13 Faculty: quantitative considerations
An appropriate number of qualified faculty members shall be used for each continuing
pharmacy education program.
EDUCATIONAL PROGRAM DEVELOPMENT
Educational program development requires thorough advance planning. Means of
determining educational needs of the target audience should be developed and used.
Input from members of the target audience should be included in this process. Educational
goals and learning objectives should be appropriate for the intended audience.
CRITERION 15 Appropriate subject matter
Continuing pharmacy education programs shall address topics and subject matter areas
which are pertinent to the contemporary practice of pharmacy and are presented in a well-
balanced manner.
CRITERION 16 Educational needs assessment
Continuing pharmacy education programs shall be designed to satisfy educational needs
which have been determined to be appropriate for the targeted audience(s). Providers
shall regularly assess educational needs and involve members of the intended pharmacist
audience(s) in identifying their own continuing education needs.
CRITERION 17 Non-commercialism
All continuing pharmacy education (CPE) programs should provide for an in-depth
presentation with fair and full disclosure and equitable balance. Appropriate topics and
learning activities shall be distinguished from topics and learning activities which are
promotional or appear to be intended for the purpose of endorsing either a specific
Updated 4/07
Page 10
commercial drug or other commercial product (as contrasted with the generic product/drug
entity and its contents or the general therapeutic area it addresses), or a specific
commercial service (as contrasted with the general service area and/or the aspects or
problems of professional practice it addresses). Note: this revised criterion and its
accompanying guidelines were adopted by ACPE in October 2006 from the Accreditation
Council for Continuing Medical Education. The guidelines are posted at http://www.acpe-
accredit.org/ceproviders/standards.asp
CRITERION 18 Educational objectives
Continuing education programs shall involve planning which includes written educational
goals and specific learning objectives that are measurable and which may serve as a basis
for evaluating the program's effectiveness.
CRITERION 19 Topic development
Each continuing education activity shall be designed to explore one subject or a group of
closely related subjects. If the activity involves multiple components, such as in a lecture
series, all segments shall be devoted to integrally related subjects.
CRITERION 20 Instructional materials
All supportive and supplemental instructional materials shall be suitable and appropriate,
and shall be periodically reviewed to assure technical quality, timeliness and currency of
content.
METHODS OF DELIVERY
The methods employed in the delivery of continuing pharmacy education play an important
role in the effectiveness of the continuing education experience. Innovation and
experimentation with delivery methods are encouraged.
CRITERION 21 Instructional delivery methods
The method(s) of delivery used in an educational program shall be determined by giving
appropriate consideration to such factors as the educational content and learning
objectives, as well as the size and the composition of the intended audience.
CRITERION 22 Participant involvement in learning
The method of delivery shall allow for and encourage active participation and involvement
on the part of the pharmacist participant.
Updated 4/07
Page 11
